Memorial Sloan-Kettering Cancer Center

Program support
To support the thalassemia collaborative research project. Scientists and physicians at MSKCC's Center for Cell Engineering and the Department of Pediatrics, along with colleagues at other institutions in the US and abroad, are working to develop a gene therapy-based cure for β-thalassemia major.

The Memorial Sloan-Kettering Cancer Center was founded in 1884 as the New York Cancer Hospital. Later called the Memorial Hospital, it merged with the Sloan-Kettering Institute, a biomedical research institution, to form the Memorial Sloan-Kettering Cancer Center in 1980. The Center integrates patient care, research, and educational programs with the goal of discovering more effective strategies to prevent, control, and ultimately cure cancer and other related diseases.